Vident Investment Advisory’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,618
| Closed | -$370K | – | 988 |
|
|
2023
Q2 | $370K | Buy |
6,618
+384
| +6% | +$21.4K | 0.01% | 794 |
|
|
2023
Q1 | $348K | Buy |
+6,234
| New | +$348K | 0.01% | 900 |
|
|
2022
Q1 | – | Sell |
-12,147
| Closed | -$1.81M | – | 1341 |
|
|
2021
Q4 | $1.81M | Buy |
12,147
+9
| +0.1% | +$1.34K | 0.05% | 494 |
|
|
2021
Q3 | $1.77M | Sell |
12,138
-844
| -7% | -$123K | 0.05% | 487 |
|
|
2021
Q2 | $2.54M | Buy |
12,982
+15
| +0.1% | +$2.94K | 0.08% | 310 |
|
|
2021
Q1 | $2.35M | Buy |
12,967
+7,086
| +120% | +$1.28M | 0.08% | 298 |
|
|
2020
Q4 | $833K | Buy |
+5,881
| New | +$833K | 0.03% | 589 |
|